SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-015742
Filing Date
2021-03-16
Accepted
2021-03-16 17:00:45
Documents
72
Period of Report
2021-01-31

Document Format Files

Seq Description Document Type Size
1 10-Q f10q0121_enzobiochem.htm 10-Q 655095
2 CERTIFICATION OF ELAZAR RABBANI, PH.D. PURSUANT TO SECTION 302 OF THE SARBANES-O f10q0121ex31-1_enzobiochem.htm EX-31.1 10212
3 CERTIFICATION OF DAVID BENCH PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT O f10q0121ex31-2_enzobiochem.htm EX-31.2 10175
4 CERTIFICATION OF ELAZAR RABBANI, PH.D f10q0121ex32-1_enzobiochem.htm EX-32.1 4555
5 CERTIFICATION OF DAVID BENCH f10q0121ex32-2_enzobiochem.htm EX-32.2 4480
  Complete submission text file 0001213900-21-015742.txt   4572973

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE enz-20210131.xml EX-101.INS 947578
7 XBRL SCHEMA FILE enz-20210131.xsd EX-101.SCH 58279
8 XBRL CALCULATION FILE enz-20210131_cal.xml EX-101.CAL 40993
9 XBRL DEFINITION FILE enz-20210131_def.xml EX-101.DEF 239009
10 XBRL LABEL FILE enz-20210131_lab.xml EX-101.LAB 463132
11 XBRL PRESENTATION FILE enz-20210131_pre.xml EX-101.PRE 249038
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 21746718
SIC: 8071 Services-Medical Laboratories